Premium
In‐hospital outcome of peripheral vascular intervention in dialysis‐dependent end‐stage renal disease patients
Author(s) -
Moussa Pacha Homam,
Alkhadra Yasser,
Darmoch Fahed,
Soud Mohamad,
Mamas Mamas A.,
Moussa Pacha Abdulghani,
Zaitoun Anwar,
Kaki Amir,
AlJaroudi Wael A.,
Alraies M. Chadi
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28522
Subject(s) - medicine , dialysis , interquartile range , kidney disease , renal function , end stage renal disease , stroke (engine) , myocardial infarction , hemodialysis , surgery , vascular disease , critical limb ischemia , mace , percutaneous coronary intervention , cardiology , revascularization , mechanical engineering , engineering
Background The impact of end‐stage renal disease (ESRD) on peripheral vascular intervention (PVI) outcome remains incompletely elucidated. Objectives We sought to compare the outcome of PVI in dialysis patients with those with normal kidney function. Methods Using weighted data from the National Inpatient Sample database between 2002 and 2014, we identified all peripheral artery disease (PAD) patients aged ≥18 years that underwent PVI. Multivariate logistic regression analysis was performed to examine in‐hospital outcomes. Results Of 1,186,192 patients who underwent PVI, 1,066,830 had normal kidney function (89.9%) and 119,362 had ESRD requiring dialysis (10.1%). Critical limb ischemia was more prevalent in dialysis patients (63.2 vs. 34.0%, p < .001). Compared with normal kidney function group, ESRD requiring dialysis was associated with higher in‐hospital mortality (1.5 vs. 4.2%, adjusted OR: 2.13 [95% CI: 2.04–2.23]) and longer length of hospital stay (median 3 days, Interquartile range [IQR] (0–6) vs. 7 days, IQR (4–18); p < .001). Dialysis patients had higher incidence of major adverse cardiovascular events (composite of death, myocardial infarction, or stroke; 14.3 vs. 9.8%, p < .001) and net adverse cardiovascular events (composite of MACE, major bleeding, or vascular complications; 40.8 vs. 29.1%, p < .001). ESRD patients less frequently underwent open bypass (5.6 vs. 8.5%, p < .001) and more frequently had major amputation (10.3 vs. 3.0%, p < .001) compared with normal kidney function group. Conclusion PAD patients on dialysis who underwent PVI have higher rates of mortality and adverse outcomes as compared to those with normal kidney function.